Targeting the Brain Leptin-Melanocortin Pathway to Treat Heart Failure

Ana C. M. Omoto, Jussara M. do Carmo, Alan J. Mouton, Zhen Wang, Xuan Li, Robert Spitz, John E. Hall, Alexandre A. da Silva · 2024

Read Targeting the Brain Leptin-Melanocortin Pathway to Treat Heart Failure by Ana C. M. Omoto, Jussara M. do Carmo, Alan J. Mouton, Zhen Wang, Xuan Li, Robert Spitz, John E. Hall, Alexandre A. da Silva (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11607000.txt.

Description

Ana C M Omoto and co-authors present a 2024 review on treating heart failure through a brain hormone pathway. Leptin's heart effects have looked contradictory, the authors argue, because most studies missed its brain route. Activating leptin receptors in the brain, without raising blood leptin, strongly improved heart metabolism and function in their lab's work after heart attack.

The benefit runs through brain neurons that switch on melanocortin 4 receptors downstream. Chronic activation of this brain pathway protected failing hearts in animal studies. How the brain talks back to the heart remains unclear, and the authors map the open questions that new therapies would need answered.

Catalog record

CREATORAna C. M. Omoto, Jussara M. do Carmo, Alan J. Mouton, Zhen Wang, Xuan Li, Robert Spitz, John E. Hall, Alexandre A. da Silva
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11607000

Browse the full library · About the Tower of Babel